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ARTICLE OPEN ACCESS
Accuracy of identifying incident stroke cases from
linked health care data in UK Biobank
Kristiina Rannikmäe, PhD,* Kenneth Ngoh,* Kathryn Bush,* Rustam Al-Shahi Salman, PhD,
Fergus Doubal, PhD, Robin Flaig, David E. Henshall, Aidan Hutchison, John Nolan, Scott Osborne,
Neshika Samarasekera, PhD, Christian Schnier, PhD, Will Whiteley, PhD, Tim Wilkinson, Kirsty Wilson,








In UK Biobank (UKB), a large population-based prospective study, cases of many diseases are
ascertained through linkage to routinely collected, coded national health datasets. We assessed
the accuracy of these for identifying incident strokes.
Methods
In a regional UKB subpopulation (n = 17,249), we identified all participants with ≥1 code
signifying a first stroke after recruitment (incident stroke-coded cases) in linked hospital
admission, primary care, or death record data. Stroke physicians reviewed their full electronic
patient records (EPRs) and generated reference standard diagnoses. We evaluated the number
and proportion of cases that were true-positives (i.e., positive predictive value [PPV]) for all
codes combined and by code source and type.
Results
Of 232 incident stroke-coded cases, 97% had EPR information available. Data sources were
30% hospital admission only, 39% primary care only, 28% hospital and primary care, and 3%
death records only. While 42% of cases were coded as unspecified stroke type, review of EPRs
enabled a pathologic type to be assigned in >99%. PPVs (95% confidence intervals) were 79%
(73%–84%) for any stroke (89% for hospital admission codes, 80% for primary care codes) and
83% (74%–90%) for ischemic stroke. PPVs for small numbers of death record and hemorrhagic
stroke codes were low but imprecise.
Conclusions
Stroke and ischemic stroke cases in UKB can be ascertained through linked health datasets with
sufficient accuracy for many research studies. Further work is needed to understand the ac-
curacy of death record and hemorrhagic stroke codes and to develop scalable approaches for
better identifying stroke types.
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Stroke is the second commonest cause of death worldwide
and a major global cause of disability.1 Very large prospective
population-based studies are needed to improve our un-
derstanding of its risk factors and causal associations.2
UK Biobank (UKB) is a prospective population-based cohort
study with extensive phenotypic and genotypic information on
>500,000 participants from England, Scotland, and Wales
(ukbiobank.ac.uk). It is an open-access resource, established to
facilitate research into the determinants of a wide range of health
outcomes, particularly those of relevance inmiddle and older age.3
A cost-effective way of following UKB participants for disease
outcomes is via linkages to routinely collected, coded, national
administrative health datasets. UKB receives regularly upda-
ted linkages to national hospital admission and death record
data for all participants, and to primary care data for a large
and increasing subset. However, appropriate use of these data
in research studies requires understanding of their accuracy.
In a systematic review of published studies, we found that
stroke-specific diagnosis codes in hospital admission and
death record data generally have good accuracy. However, the
studies varied widely in their settings and methodology, with
very limited data about the accuracy of primary care codes or
the effect of combining different data sources.4
We therefore conducted a validation study to assess the ac-
curacy of ascertainment of incident stroke cases in UKB via
linked coded national administrative health datasets (in-
cluding primary care data), compared with diagnoses assigned
following adjudication by clinical experts with access to the
full free-text electronic patient records (EPRs).
Methods
Study population
We conducted the study in a subpopulation of 17,249 UKB
participants in the Lothian region of southeast Scotland, all of
whom are linked to national administrative health datasets (in-
cluding hospital, primary care, and death record codes). This
region encompasses the city of Edinburgh, where one of UKB’s
recruitment centers was located. Within this subpopulation, we
identified all those with at least one code in their linked health data
that indicated a stroke diagnosis after their recruitment to UKB.
Stroke definition
We defined stroke according to the WHO definition: “rapidly
developing clinical signs of focal (or global) disturbance of ce-
rebral function, lasting more than 24 hours or leading to death,
with no apparent cause other than that of vascular origin.”5
Code selection and sources
We selected and included relevant codes from hospital ad-
mission, primary care, and death records up to the end of
September 2015, the date at which data were complete for all
sources at the time of this study.
In the United Kingdom, hospital admissions and death records
are coded by specialized medical coders, who use the In-
ternational Classification of Diseases (ICD; currently version
10) coding system to assign a primary code to the main con-
dition resulting in a particular admitted episode of care, and
secondary codes to other conditions. Primary care data are
coded by general practice clinical or administrative staff during
clinical encounters or on receipt of information from elsewhere
(e.g., hospital inpatient and specialist outpatient settings).
Primary care data in the United Kingdom currently use the
Read coding system (version 2 in Scotland during the time
period of relevance in this study).
We selected relevant stroke codes from the ICD-10 and Read
version 2 coding systems, aiming to ascertain cases of stroke with
a high positive predictive value (PPV) (i.e., to minimize the
proportion of false-positives among the stroke cases), while
aiming to ascertain as many as possible of the true cases
(i.e., optimizing sensitivity). Our code selections were informed
by the results of a systematic review,4 browsing of theTechnology
Reference Data Update Distribution Service (isd.hscic.gov.uk/
trud3/user/guest/group/0/home), the Secure Anonymised In-
formation Linkage databank cerebrovascular diseases dictionary,6
the Quality Outcomes Framework indicator sets for stroke
(www.wales.nhs.uk/), and the CALIBER online data portal
(www.caliberresearch.org/), as well as manual review of code lists
by experts (table e-1, dryad.org/10.5061/dryad.w9ghx3fk0).
We only validated diagnoses for cases with their first incident
stroke, defined as the first-ever-in-a-lifetime occurrence of
a WHO-defined stroke according to codes from linked na-
tional administrative datasets. We excluded participants who
self-reported a stroke at baseline recruitment or who had
a stroke code in their linked health care data predating re-
cruitment to UKB. This was because (1) incident disease
cases (i.e., new-onset disease arising in those without a history
of the relevant condition) are of most research interest in
a prospective, population-based study recruiting mainly
healthy volunteers and (2) a large proportion of stroke cases
identified through codes or self-reported stroke status arising
prior to recruitment (prevalent cases) predated the EPR
system used for validation. We based our analyses on the
earliest code(s) for each participant from any data source.
Glossary
CI = confidence interval; EPR = electronic patient record; ICD = International Classification of Diseases; ICH = intracerebral
hemorrhage; PPV = positive predictive value; SAH = subarachnoid hemorrhage; UKB = UK Biobank.
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Process of assigning an expert diagnosis
For each included participant with a stroke code, we extracted,
anonymized, and created a single document (hereafter referred
to as a “vignette”) from all available relevant medical in-
formation from the secondary care EPR system, including
outpatient clinic letters, hospital discharge summaries, and
formal radiologic investigation reports (figure e-1, dryad.org/
10.5061/dryad.w9ghx3fk0). We considered information rele-
vant if it was associated with a hospital admission leading to the
code, or if it was within 2 months before or after the date of
a relevant primary care code. A 2-month windowwas chosen to
reflect local clinical practice during the time period of the study:
patients in NHS Lothian with a suspected stroke or TIA not
requiring hospital admission would have been referred to the
neurovascular specialist outpatient clinic, where they would
usually be seen within 1 week, in keeping with national
guidelines (the National Institute for Health and Care Excel-
lence guidance, www.nice.org.uk/guidance/cg68, and the
Scottish Stroke Care Audit Standards, strokeaudit.scot.nhs.uk/
Quality/Scottish_Stroke_Care_Standards.html).
Following this specialist clinic visit, correspondence to the
patient’s general practitioner would generally appear on the
secondary care EPR systemwithin days to a fewweeks, providing
the clinical information required to validate primary care codes.
We developed an adjudication form, which included a sum-
mary for adjudicators of criteria for the diagnosis of stroke, its
pathologic types (ischemic stroke, intracerebral hemorrhage
[ICH], subarachnoid hemorrhage [SAH]), and subtypes
(appendix e-1, dryad.org/10.5061/dryad.w9ghx3fk0).
Six consultant stroke specialists (hereafter referred to as
“adjudicators”) completed adjudication forms based on the
information in the EPR-derived vignettes. They did not have
access to review the brain imaging themselves, but formal scan
reports were included in the vignettes. One adjudicator (K.R.)
completed the forms for all participants and 5 other adjudi-
cators (N.S., C.S., R.A.-S.S., F.D., W.W.) independently
completed the forms (each for a subset) to allow assessment
of interadjudicator agreement. All adjudicators were blinded
to which specific codes had led to ascertainment of any case
and to each other’s diagnoses. The first adjudicator’s di-
agnoses were used as the reference standard for the primary
analyses in this study.
Data analyses
Participants’ characteristics
We summarized participants’ sex and median age at re-
cruitment and at the time the code was assigned.
Code source and type identification
We calculated the number and proportion of stroke-coded
participants arising from each data source. We also stratified
the codes into those specifying a stroke type (ischemic vs ICH
vs SAH) vs those indicating an unspecified type of stroke, and
calculated the numbers and proportions of these arising from
each source. We compared these findings with the same
analyses for the larger subset of all UKB participants with
linkage to the relevant data sources in England, Scotland, and
Wales.
Assessment of interadjudicator agreement
We used percent agreement and Cohen kappa (ĸ)7 to mea-
sure interadjudicator agreement, comparing one adjudicator’s
(K.R.) diagnoses with a second (one of N.S., C.S., R.A.-S.S.,
F.D., W.W.) for the following: stroke vs not; stroke/TIA vs
not; and, in cases where both adjudicators agreed that the
diagnosis was stroke, ischemic stroke vs ICH vs SAH vs un-
certain stroke type.
Calculating code accuracy
The main measure of accuracy assessed in this study was PPV
(the proportion of all stroke-coded cases ascertained that were
true-positive cases). While we could not directly assess sensi-
tivity, we were able to assess the effects on both PPV and the
number of true-positive cases (a higher number of true-
positives indicates higher sensitivity) of different code combi-
nation strategies for ascertaining cases. We categorized the
stroke-coded cases as true-or false-positives based on adjudi-
cators’ diagnoses. We calculated the PPV and its 95% confi-
dence interval (CI) using the Clopper Pearson exact method,
considering both (1) only an adjudicator diagnosis of stroke
a true-positive and (2) an adjudicator diagnosis of stroke or
TIA a true-positive. To understand the contribution of each
source of codes, we calculated PPVs for each code source
separately (hospital admission vs primary care vs death record
data) and for their combinations, and explored the effect (both
on PPV and on true-positive case numbers) of including only
codes in the primary position for hospital admission data.
We also calculated PPVs for ischemic and hemorrhagic stroke
types, and explored the effect (both on PPV and on true-
positive case numbers) of restricting hospital data to codes in
the primary position and of treating all unspecified stroke type
codes as ischemic stroke codes.
In further analyses, we assessed administrative vs overall code
accuracy and the effect on resulting PPVs, as we hypothesized
that this may explain some of the variability of the results
among previous validation studies. Some validation studies are
based on the assumption that if the diagnostic code reflects the
diagnosis mentioned somewhere in the EPR (often, for ex-
ample, the discharge summary for a particular hospital admis-
sion), then this is sufficient to confirm the accuracy of the
code.4 We refer to this as the administrative accuracy of
the code. Clinicians will, however, appreciate that assessing the
accuracy of a diagnostic code is more nuanced. A patient’s true
diagnosis may emerge over time after encounters with several
different clinicians with varying levels of expertise and with
access to different amounts of relevant information; hence, the
EPR can contain inconsistencies, which may require specialist
clinical knowledge to detect and/or resolve. Hence a specialist
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physician’s review of all relevant parts of the complete EPR will
give a more accurate picture of the true diagnosis and so of the
code accuracy, which we refer to as the overall accuracy. We
assessed administrative accuracy by having a primary care
physician in our team review the EPR-derived vignettes for
mentions of stroke diagnoses. We assessed overall accuracy by
having expert adjudicators (consultant level stroke specialists)
review the EPR-derived vignettes and derive reference standard
diagnoses based on all available information and their clinical
interpretation of this information (see Process of assigning an
expert diagnosis). We then assessed whether, and by how
much, the administrative vs overall accuracy (PPV) differed for
our selected stroke codes.
We performed all statistical analyses in R (r-project.org).
Further exploration of false-positive codes
We compared characteristics of participants with a true- vs
a false-positive code and reviewed the vignettes of false-
positive cases, considering their alternative diagnoses and
assessing possible reasons for them being assigned a stroke
code. Informed by these assessments, we evaluated alternative
code combinations that we hypothesized may improve code
accuracy.
Stroke type and subtype distributions
We further assessed the proportion of true-positive cases that
could be assigned a pathologic stroke type (ischemic stroke,
ICH, SAH) and more detailed subtype by the stroke specialist
adjudicator, and their frequency distributions.
Standard protocol approvals, registrations,
and patient consents
All procedures performed in studies involving human partic-
ipants were in accordance with the ethical standards of the
institutional and/or national research committee and with the
1964 Helsinki declaration and its later amendments or com-
parable ethical standards. As part of the UKB recruitment
process, informed consent was obtained from all individual
participants included in the study.
Data availability
Anonymized summary data based on this study not published
within this article can be shared (subject to approval from
UKB) on request from any qualified investigator unless lim-
ited by ethical or legal restrictions. Any bona fide researcher
can access the UKB resource for research that aims to benefit
the public’s health (see ukbiobank.ac.uk).
Results
Study population
In the subpopulation of 17,249 participants, 232 had a relevant
stroke code occurring after recruitment to UKB. Of these, 225
(97%) had available information in their EPR to create a vi-
gnette and were included in the study analyses (figure 1).
Participants’ characteristics
Of the 225 stroke-coded cases, 111 (49%) were female. Me-
dian age at recruitment to UKB was 63 years (range 41–70
Figure 1 Selection of included UK Biobank (UKB) participants
GP = general practitioner; NHS = National Health Service.
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years) and at time of the stroke code was 67 years (range
45–76 years) (table 1).
Code sources and types
Of the 225 stroke-coded cases, 67 (30%) received a code from
hospital admission data only, 87 (39%) from primary care
data only, 64 (28%) from both hospital admission and pri-
mary care data, 6 (3%) from death records only, and one from
both hospital admission data and death records (table 2 and
figure e-2, dryad.org/10.5061/dryad.w9ghx3fk0). For the
larger subset of all UKB participants with linkage to the rel-
evant data sources, these proportions were similar for Scot-
land, but a higher proportion of participants in England and
Wales had hospital-only codes (table 2).
As regards stroke types, 131/225 (58%) of stroke-coded cases
had a stroke type-specific code (ischemic, ICH, or SAH),
while the remaining 94 (42%) had unspecified stroke codes.
The proportion of cases with unspecified stroke type codes
was higher among those ascertained from primary care (105/
151 [70%]) than from hospital admission data (38/132
[29%]), and all death record codes were stroke-type specific
(for these code-source level estimates, a case would be
counted ≥1 if occurring in ≥1 source) (table 3 and figure e-2,
dryad.org/10.5061/dryad.w9ghx3fk0). Among the larger
subset of all UKB participants with relevant linked data, the
proportion of cases with an unspecified stroke code was
similar for Scotland, but lower for England and Wales (19%
and 30%, respectively) (table 3).
Table 1 Participant characteristics
All coded cases (n = 225) True-positive cases (n = 178) False-positive cases (n = 47)
Female 49 (111/225) 47 (84/178) 57 (27/47)
Recruitment age, y 63 (41–70) 63 (41–70) 64 (46–69)
Age at code, y 67 (45–76) 67 (45–76) 67 (52–76)
Primary care code only 33 (75/225) 26 (47/178) 60 (28/47)
Unspecified stroke code 42 (86/225) 38 (68/178) 38 (18/47)
Hemorrhagic stroke code 22 (49/225) 20 (35/178) 30 (14/47)
Code date <2011 34 (76/225) 33 (58/178) 38 (18/47)
Dead by end of follow-up (any cause) 8 (18/225) 7 (13/178) 11 (5/47)
Values are % (n) or median (range).
Table 2 Code sources in the validation study subpopulation and in the larger subset of all UK Biobank (UKB) participants
linked to relevant health care datasets in Scotland, England, and Wales
UKB participants, Scotland,
Lothian (n = 17,249)
UKB participants,
Scotland, alla (n = 31,426)
UKB participants,
England, alla (n = 18,494)
UKB participants,
Wales, alla (n = 21,346)
Total stroke codes 225 553 197 301
Hospital only codes 30 (67/225) 27 (147/553) 42 (82/197) 43 (129/301)
Primary care only codes 39 (87/225) 44 (241/553) 29 (58/197) 39 (116/301)
Death record only codes 3 (6/225) 1 (7/553) 0 (0/197) 3 (10/301)
Hospital and primary care
codes
28 (64/225) 28 (156/553) 29 (57/197) 14 (43/301)
Hospital and death record
codes
0 (1/225) 0 (2/553) 0 (0/197) 1 (2/301)
Primary care and death
record codes
0 (0/225) 0 (0/553) 0 (0/197) 0 (0/301)
Hospital and primary care
and death record codes
0 (0/225) 0 (0/553) 0 (0/197) 0 (1/301)
Values are % (n).
a We included UKB participants with linkage to hospital admissions data, death records, and primary care data (whereas around half of UKB participants are
linked to primary care data using Read V2 or V3 coding systems, we included only practices using the Read V2 coding system for ease of comparison).
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Interadjudicator agreement
All vignettes were independently reviewed by 2 adjudicators. For
assigning a diagnosis of stroke vs not, interadjudicator agreement
was 91% and Cohen kappa very good at 0.7 (95% CI, 0.6–0.8);
for stroke/TIA vs not, agreementwas 93% andCohen kappa very
good at 0.7 (95% CI, 0.6–0.9). Agreement for assigning a stroke
type (ischemic stroke vs ICH vs SAH vs uncertain stroke type)
was 99% and Cohen kappa excellent at 0.98 (95% CI, 0.9–1).
Code accuracy
The overall PPV of case ascertainment for all 225 stroke-
coded cases from all sources combined was 79% (95% CI,
73%–84%). When broken down by code source, PPV was
highest for the 132 cases with hospital admission codes (89%;
95% CI, 82%–94%), and higher still when limiting analyses to
primary position hospital codes only (94%; 95% CI,
88%–98%), at the expense of losing a few (<10%) true-
positive cases. PPV for the 151 cases with primary care codes
was 80% (95% CI, 72%–86%). Only 7 cases had death record
codes, with PPV 57% (95% CI, 18%–90%), the wide CIs
indicating limited precision of this estimate. For cases with
both a hospital admission and a primary care code, PPV was
very high (97%; 95% CI, 89%–100%), but only a third of the
cases fell into this category (figure 2A).
As regards the accuracy of identifying stroke pathologic type
(for these estimates, a case would be counted in ≥1 analysis if it
had ≥1 unique stroke type code), PPV among the 88 partic-
ipants with an ischemic stroke code was 83% (95% CI,
74%–90%); restricting to primary position codes (for those
cases from hospital admission data) increased this to 86% (95%
CI, 76%–93%), with loss of <10% of true-positive cases (figure
2B). Given that ischemic stroke is the most common patho-
logic stroke type, and hence an unspecified stroke code is much
more likely to signify an ischemic rather than a hemorrhagic
stroke case, we calculated the PPV for ischemic stroke of the
184 ischemic and unspecified stroke codes combined. While
this resulted in a slightly lower PPV of 80% (95% CI,
73%–85%), it approximately doubled the number of true-
positive ischemic stroke cases identified. The proportion of
true-positive ischemic stroke cases among all cases with an
unspecified code was 77%. Accuracy of hemorrhagic stroke
codes was lower but the small numbers of coded cases resulted
in limited precision: PPV among 26 participants with an ICH
code was 42% (95% CI, 23%–63%) and among 24 participants
with a SAH code was 71% (95% CI, 49%–87%). Restricting to
primary position codes increased the PPV of both ICH and
SAH codes without losing any true-positive cases.
PPV when measuring only administrative accuracy was 93%, de-
creasing to 79% when measuring overall accuracy. This demon-
strates the importance of expert-led adjudication in validation
studies, as ignoring it would lead to falsely inflated PPVs (figure 3).
Further exploration of false-positive codes
The 47 false-positive stroke-coded cases had a similar pro-
portion of unspecified codes and median age (at date of re-
cruitment or first stroke code) as true-positives. False-positive
cases were more likely to have a primary care code and to have
died by the end of follow-up, and were slightly more likely to
be female, to have a hemorrhagic stroke code, and to have an
earlier first stroke code date (table 1).
Alternative diagnoses for the 47 false-positives included TIA
(14/47, 30%); secondary intracranial bleed not due to SAH or
ICH (e.g., traumatic, tumor-related, bleeding into a cerebral
infarct) (11/47 [23%]); radiologic finding of a suspected old
vascular lesion (usually incidental) (8/47 [17%]); and pos-
sible or probable alternative diagnosis (e.g., migraine, de-
myelination, seizure, or another diagnosis) (14/47 [30%]).
Table 3 Proportion of cases with unspecified vs specified stroke type codes in the validation study subpopulation and in
the larger subset of all UKBiobank (UKB) participants linked to relevant health care datasets in Scotland, England,
and Wales
UKB participants, Scotland,
Lothian (n = 17,249)
UKB participants,
Scotland, alla (n = 31,426)
UKB participants, England,
alla (n = 18,494)
UKB participants, Wales,
alla (n = 21,346)
Total stroke codes 225 553 197 301
Unspecified codes in
hospital data
29 (38/132) 27 (81/305) 7 (10/139) 17 (30/175)
Unspecified codes in
primary care
70 (105/151) 64 (254/397) 45 (52/115) 50 (80/160)
Unspecified codes in
death records
0 (0/7) 11 (1/9) n/a 54 (7/13)
Unspecified codes
totalb
42 (94/225) 40 (219/553) 19 (37/197) 30 (89/301)
Values are % (n).
a We included UKB participants with linkage to hospital admissions data, death records, and primary care data (whereas around half of UKB participants are
linked to primary care data using Read V2 or V3 coding systems, we included only practices using the Read V2 coding system for ease of comparison).
b % Stroke-coded cases with an unspecified stroke type code (note that if a case has codes from multiple sources, including a specified stroke type code in
hospital data and an unspecified stroke type code in primary care data or death record data, they will count as having a specified code).
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Among the 15 participants with a false-positive ICH code, 7/15
had another primary stroke type ± secondary ICH, 4/15
intratumor bleed, 3/15 traumatic or other intracranial bleed,
and 1/15 no obvious reason for an ICH code. Among the 7
participants with a false-positive SAH code, 4/7 were traumatic
intracranial bleed, 2/7 another primary stroke type ± secondary
SAH component, and 1/7 asymptomatic aneurysm.
Because performance for hemorrhagic stroke codes was
suboptimal, having observed that the more common alter-
native diagnoses were traumatic and intratumor bleeds or
stroke complicated by a bleed, we performed additional
analyses to explore the effects of different code inclusion
criteria on numbers of cases, numbers of true-positives, and
PPV for ICH and SAH. For both ICH and SAH, we could
increase PPV but at the expense of failing to detect some true-
positive cases. However, numbers of cases were too small to
draw firm conclusions (figure 4).
Stroke type and subtype distributions
With information from the EPR, a stroke specialist was able to
assign a pathologic stroke type to 177 of the 178 true-positive
stroke cases: 149 (84%) were ischemic, 11 (6%) ICH, and 17
(10%) SAH. Depending on the subclassification system used,
an ischemic subtype could be determined for 37%–87% of
cases, an ICH subtype for 27%–100% of cases, and SAH
subtype for 94% of cases (figure e-3, dryad.org/10.5061/
dryad.w9ghx3fk0).
Discussion
Our results suggest that stroke cases, and cases of ischemic
stroke type, can be ascertained in UKB through linked coded
data with sufficient accuracy for use in many genetic and
epidemiologic research studies without further expert vali-
dation, since PPVs were generally at least 80% despite
Figure 2 Positive predictive values (PPVs) of stroke codes
PPVs of stroke codes stratified by code source (A) and code type (B). Primary position: includes primary care codes, where no code position is specified, and
only primary position hospital admission codes. CI = confidence interval; ICH = intracerebral hemorrhage; SAH = subarachnoid hemorrhage.
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stringent adjudication criteria. Primary care is an important
code source with ≥1/3 of the cases ascertained exclusively
via primary care data in this UK setting. Code accuracy
appeared slightly better for hospital admission compared to
primary care codes. There were insufficient data to draw firm
conclusions regarding the accuracy of death record or
hemorrhagic stroke type codes. Including only the primary
position codes from hospital admission data increased PPV
without loss of a substantial proportion of true-positive
cases. In the subpopulation of Scotland studied, only around
60% of codes were specific for a stroke type; however, using
all available relevant medical information from the EPR, an
expert adjudicator could assign a stroke type to 99%, and
a more detailed stroke subtype to between a third and almost
90% of cases, depending on the subclassification system
used. A higher proportion of participants had a specified
stroke type code in the English and Welsh data, but the
accuracy of these codes needs further investigation. We also
demonstrated that, at least in this setting, considering only
the administrative accuracy of stroke diagnosis codes (rather
than overall accuracy based on an expert review of the full
EPR) may give falsely inflated PPVs.
Acceptable levels of accuracy, and the relative importance
of different accuracy metrics, depend on the context.8 UKB
is primarily used for research into the genetic and non-
genetic determinants of disease.3 In such analyses, it is
important to ensure that a high proportion of participants
identified as disease cases truly do have the disease (high
PPV) to minimize bias in effect estimates, while aiming to
optimize statistical power by ascertaining as many true-
positive cases as possible (optimizing sensitivity, but not
necessarily maximizing it, as this may compromise the
PPV). A high specificity (the proportion of participants
without the disease that do not receive a stroke code) is
crucial in obtaining a high PPV, but is not sufficient in and
of itself. In population-based prospective cohorts where the
proportion of all participants who are true-positives for
the disease (in this case stroke) is generally low, the pro-
portion of all participants incorrectly classified as having
stroke (false-positives) will generally be low (giving high
specificity), even if the absolute number of false-positives is
high compared to the absolute number of true-positives
(low PPV).8 Providing appropriate codes are used, both
the specificity and negative predictive value of routinely
collected health care data to identify disease cases
in population-based studies are usually very high
(96%–100%).4 For these reasons, we focused on estimating
the PPV of using routinely collected health care data to
identify stroke cases in UKB, and on assessing the effects of
different code and source selections on both PPV and
number of true-positive cases.
Strengths of this study include (1) the overall large number of
participants; (2) inclusion of primary care and death record
codes for which accuracy data have previously been limited;
(3) creation of vignettes using preset criteria from the EPR for
97% of otherwise eligible stroke-coded cases, thus avoiding
Figure 3 Assessing administrative vs overall accuracy
High clinical certainty mentions of stroke: “stroke,” “probable stroke,” “presumptive stroke,” “consistent with stroke,” “compatible with stroke,” “likely stroke,”
“treated as stroke” or equivalent stroke terms (ICH, SAH, intracerebral hemorrhage, subarachnoid hemorrhage, ischemic stroke, infarct). Medium clinical
certainty mentions of stroke: including above plus “possible stroke,” “suspected stroke,” “impression of stroke,” “suggestive of stroke,” “query stroke,” or
equivalent stroke terms (ICH, SAH, intracerebral hemorrhage, subarachnoid hemorrhage, ischemic stroke, infarct). Low clinical certainty mentions of stroke
include above plus “TIA” and “transient ischaemic attack” with any level of certainty preceding it. The hierarchy of clinical certainty was based on the ICD-10
clinical coding instruction manual (isdscotland.org/Products-and-Services/Terminology-Services/Clinical-Coding- Guidelines/, April 2010 version), which is
used by the coding departments in UK hospitals. CI = confidence interval; PPV = positive predictive value.
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the bias of selecting participants with a higher prior proba-
bility of having had a stroke; (4) blinding of adjudicators to
codes and each other’s diagnoses; (5) assessment of inter-
adjudicator reliability; (6) further analysis of false-positive
codes; and (7) assessment of both administrative and overall
accuracy, demonstrating the importance of an expert-led
reference standard in validation studies.
There are some limitations: (1) small numbers precluded
robust conclusions about the accuracy of death record and
hemorrhagic stroke codes; (2) our lack of access to the full
free text EPRs held exclusively by the primary care system
may have led to slightly more conservative PPV estimates
(although we would not expect this to be a major issue for
stroke), as almost all stroke cases have acute inpatient or
outpatient management in secondary care (in keeping with
this is that we were able to find secondary care records for
97% of the cases) and information provided from primary
to secondary care was available in the hospital EPR; (3) the
potential difficulty in differentiating between definite false-
positive and uncertain cases from retrospective review of
medical records, which may have further reduced the es-
timated PPVs; and (4) the restriction of the current study
to a Scottish subpopulation of the UKB participants (al-
though we have no reason to suspect substantial variation
in the results considering that the code generation process
across the United Kingdom follows similar pathways and
given the broadly similar distribution of code sources in
the wider UKB population across England, Scotland, and
Wales).
The present study is limited to validating the accuracy of codes
for symptomatic stroke (as defined by the WHO). Subclinical
cerebrovascular disease (such as that detected by brain imaging),
which is more common, particularly in older people,9 would not
be readily ascertained by the linked, coded health care data
sources used to follow the health of UKB participants, but can be
detected through brain imaging conducted as part of the UKB
multimodal imaging study of 100,000 of its participants.
These results are largely consistent with those from our earlier
systematic review,4 where PPVs for stroke-specific ICD-10
hospital admission codes ranged from 79% to 83%,10,11 and
for ischemic stroke from 86% to 88%.10,12,13 Our results for
ICH and SAH code accuracy among a small number of par-
ticipants were worse than those from the 2 previous United
Kingdom–based studies of ICD-10 or Read codes.13,14 This
may be in part because these studies checked only (or mainly)
for administrative accuracy, hence inflating the PPVs. Our
results were similar to a Danish study, which also used an
expert review of medical records to check for overall accu-
racy.10 To our knowledge, there are no previous validation
studies of stroke-specific UK primary care Read codes or
death record codes for diagnosis of all types of stroke, nor of
the effect of combining primary care and hospital admission
coded data.
Figure 4 Exploratory analyses to improve accuracy of hemorrhagic stroke codes
*Excluding other stroke code sameday: excluded cases with a diagnostic code for >1 stroke pathologic type on the sameday. This was done because a patient
who has one pathologic stroke type (e.g., ischemic stroke) can sometimes develop a complication and subsequent brain scan appearances similar to another
pathologic stroke type (e.g., a patient with ischemic stroke can have a bleed in the brain as a result of the ischemic stroke, which could lead to a false diagnosis
of an intracerebral hemorrhage [ICH]). CI = confidence interval; PPV = positive predictive value; SAH = subarachnoid hemorrhage.
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Further work will be required to further explore the accuracy
of hemorrhagic stroke and death record codes in larger
numbers of cases by expanding this work to other UKB re-
cruitment locations, which will also enable assessment of the
generalizability of these results to other regions of the United
Kingdom. In our Scottish subpopulation, while over one-third
of the codes were not specific for a stroke type, expert adju-
dication allowed a stroke type to be assigned for almost all
cases. Future studies should investigate ways of automating
this process, as well as methods for determining more detailed
stroke subtypes.
Our results suggest that stroke and ischemic stroke cases in
UKB can be identified through linked coded data with
sufficient accuracy for many genetic and epidemiologic
studies, while there are currently insufficient data to draw
definite conclusions about the accuracy of hemorrhagic
stroke codes.
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